<?xml version="1.0" encoding="utf-8"?>
<!-- generator="tx_libfeedcreator" -->
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" ><channel><title>News </title><description>Helmholtz Centre for Infection Research - Press Releases </description><copyright>© Helmholtz Zentrum für Infektionsforschung</copyright><link>https://www.helmholtz-hzi.de:443/en/news-events/news/</link><lastBuildDate>Sat, 05 Sep 2020 01:23:45</lastBuildDate><managingEditor>info@helmholtz-hzi.de (Verantwortlicher)</managingEditor><language>en</language><webMaster>info@helmholtz-hzi.de (Verantwortlicher)</webMaster><category>Pressemitteilungen</category><generator>tx_libfeedcreator</generator><item><title>Drei ERC Starting Grants gehen ans HZI</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/drei-erc-starting-grants-gehen-ans-hzi/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>Der Europäische Forschungsrat (ERC) zeichnet zwei Wissenschaftlerinnen und einen Wissenschaftler des Helmholtz-Zentrums für Infektionsforschung (HZI) mit einem ERC Starting Grant aus. Die Förderungen von bis zu 1,5 Millionen Euro über einen Zeitraum von fünf Jahren erhalten Jun.-Prof. Neva Caliskan vom Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), Jun.-Prof. Gregor Fuhrmann vom…</content:encoded><description>Der Europäische Forschungsrat (ERC) zeichnet zwei Wissenschaftlerinnen und einen Wissenschaftler des Helmholtz-Zentrums für Infektionsforschung (HZI) mit einem ERC Starting Grant aus. Die Förderungen von bis zu 1,5 Millionen Euro über einen Zeitraum von fünf Jahren erhalten Jun.-Prof. Neva Caliskan vom Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), Jun.-Prof. Gregor Fuhrmann vom…</description><pubDate>Thu, 03 Sep 2020 11:24:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/drei-erc-starting-grants-gehen-ans-hzi/</guid></item><item><title>Leap forward in the fight against antibiotic resistance</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/neuer-ansatzpunkt-im-kampf-gegen-antibiotika-resistenzen/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>Bacteria show a wide range of capabilities in withstanding antibiotic treatment or attack by our immune system, which are great challenges in infection research. Scientists at the Würzburg-based Helmholtz Institute for RNA-based Infection Research (HIRI), a site of the Helmholtz Centre for Infection Research (HZI), have developed a novel approach to reading the activity of hundreds of genes in an…</content:encoded><description>Bacteria show a wide range of capabilities in withstanding antibiotic treatment or attack by our immune system, which are great challenges in infection research. Scientists at the Würzburg-based Helmholtz Institute for RNA-based Infection Research (HIRI), a site of the Helmholtz Centre for Infection Research (HZI), have developed a novel approach to reading the activity of hundreds of genes in an…</description><pubDate>Tue, 18 Aug 2020 14:00:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/neuer-ansatzpunkt-im-kampf-gegen-antibiotika-resistenzen/</guid></item><item><title>Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/startschuss-fuer-europas-groesste-initiative-zur-beschleunigung-der-entwicklung-von-therapien-fuer-c/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>The new consortium CARE (Corona Accelerated R&amp;D in Europe), supported by the Innovative Medicines Initiative (IMI) public-private partnership, announced its launch today to accelerate the discovery and development of urgently needed medicines to treat SARS-CoV-2, the virus that causes COVID-19. With a grant totalling € 77.7 million, CARE is funded by cash contributions from the European Union…</content:encoded><description>The new consortium CARE (Corona Accelerated R&amp;D in Europe), supported by the Innovative Medicines Initiative (IMI) public-private partnership, announced its launch today to accelerate the discovery and development of urgently needed medicines to treat SARS-CoV-2, the virus that causes COVID-19. With a grant totalling € 77.7 million, CARE is funded by cash contributions from the European Union…</description><pubDate>Tue, 18 Aug 2020 08:19:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/startschuss-fuer-europas-groesste-initiative-zur-beschleunigung-der-entwicklung-von-therapien-fuer-c/</guid></item><item><title>COVID-19: Immune system derails</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/covid-19-immunsystem-auf-irrwegen/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction – rather, the immune response is caught in a continuous loop of activation and inhibition. Experts from Charité – Universitätsmedizin Berlin, the University of Bonn, the German Center for Neurodegenerative Diseases (DZNE), the Helmholtz Centre for Infection Research…</content:encoded><description>Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction – rather, the immune response is caught in a continuous loop of activation and inhibition. Experts from Charité – Universitätsmedizin Berlin, the University of Bonn, the German Center for Neurodegenerative Diseases (DZNE), the Helmholtz Centre for Infection Research…</description><pubDate>Thu, 06 Aug 2020 11:00:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/covid-19-immunsystem-auf-irrwegen/</guid></item><item><title>How many people are now immune to SARS-CoV-2?</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/wie-viele-menschen-sind-heute-schon-immun-gegen-sars-cov-20-1/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>Who has overcome an infection with the virus without noticing, and how many people have already produced protective antibodies against the new coronavirus? Various antibody studies are now under way that will provide information on immunity or seroprevalence in the population. However, in order to compare these studies in a timely and reliable manner and provide a comprehensive evaluation, the…</content:encoded><description>Who has overcome an infection with the virus without noticing, and how many people have already produced protective antibodies against the new coronavirus? Various antibody studies are now under way that will provide information on immunity or seroprevalence in the population. However, in order to compare these studies in a timely and reliable manner and provide a comprehensive evaluation, the…</description><pubDate>Mon, 03 Aug 2020 10:35:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/wie-viele-menschen-sind-heute-schon-immun-gegen-sars-cov-20-1/</guid></item><item><title>SARS-CoV-2 outbreak in German meat processing plant: Transmissions took place over long distances in air-conditioned working areas</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/sars-cov-2-ausbruch-in-deutschem-fleischzerlegebetrieb-uebertragungen-erfolgten-ueber-weite-distanze/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>In a joint study of the Helmholtz Centre for Infection Research (HZI), the University Medical Center Hamburg-Eppendorf (UKE), and the Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology (HPI), the origins of the first SARS-CoV-2 outbreak in May 2020 at Tönnies in Rheda-Wiedenbrück, Germany's largest meat processing complex, were investigated. The study results have now been…</content:encoded><description>In a joint study of the Helmholtz Centre for Infection Research (HZI), the University Medical Center Hamburg-Eppendorf (UKE), and the Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology (HPI), the origins of the first SARS-CoV-2 outbreak in May 2020 at Tönnies in Rheda-Wiedenbrück, Germany's largest meat processing complex, were investigated. The study results have now been…</description><pubDate>Thu, 23 Jul 2020 11:41:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/sars-cov-2-ausbruch-in-deutschem-fleischzerlegebetrieb-uebertragungen-erfolgten-ueber-weite-distanze/</guid></item><item><title>Exploring the RNA world of the microbiota</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/rna-welt-der-mikrobiota-erforscht/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>The intestinal microbiota plays a central role for human physiology. Traditional studies have focused on the changes in microbiota composition under diverse conditions. Recently, efforts shifted towards understanding the molecular biology of intestinal bacteria. The species Bacteroides thetaiotaomicron (B. theta) has emerged as a model organism for human intestinal microbiota research. Scientists…</content:encoded><description>The intestinal microbiota plays a central role for human physiology. Traditional studies have focused on the changes in microbiota composition under diverse conditions. Recently, efforts shifted towards understanding the molecular biology of intestinal bacteria. The species Bacteroides thetaiotaomicron (B. theta) has emerged as a model organism for human intestinal microbiota research. Scientists…</description><pubDate>Thu, 16 Jul 2020 22:23:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/rna-welt-der-mikrobiota-erforscht/</guid></item><item><title>Representative, nationwide coronavirus antibody study starts in Reutlingen</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/repraesentative-bundesweite-corona-antikoerperstudie-startet-in-reutlingen/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>With the aim of obtaining a better overview of the occurrence of SARS-CoV-2 infections, a nationwide antibody study conducted by the Helmholtz Centre for Infection Research (HZI) was launched in the district of Reutlingen at the beginning of July. Alongside four other antibody tests, a new detection method being jointly developed by the NMI Natural and Medical Sciences Institute at the University…</content:encoded><description>With the aim of obtaining a better overview of the occurrence of SARS-CoV-2 infections, a nationwide antibody study conducted by the Helmholtz Centre for Infection Research (HZI) was launched in the district of Reutlingen at the beginning of July. Alongside four other antibody tests, a new detection method being jointly developed by the NMI Natural and Medical Sciences Institute at the University…</description><pubDate>Fri, 03 Jul 2020 11:00:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/repraesentative-bundesweite-corona-antikoerperstudie-startet-in-reutlingen/</guid></item><item><title>Mirror, mirror –  New enzyme group converts amino acid into its mirror image</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/spieglein-spieglein-neue-enzymgruppe-verwandelt-aminosaeure-in-ihr-spiegelbild/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>Jun Prof Jesko Köhnke heads the junior research group “Structural Biology of Biosynthetic Enzymes” at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a site of the Helmholtz Centre for Infection Research (HZI). Together with his team of three, he researches the biosynthesis of natural products. His current research on an antibiotically active natural product called…</content:encoded><description>Jun Prof Jesko Köhnke heads the junior research group “Structural Biology of Biosynthetic Enzymes” at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a site of the Helmholtz Centre for Infection Research (HZI). Together with his team of three, he researches the biosynthesis of natural products. His current research on an antibiotically active natural product called…</description><pubDate>Mon, 29 Jun 2020 17:05:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/spieglein-spieglein-neue-enzymgruppe-verwandelt-aminosaeure-in-ihr-spiegelbild/</guid></item><item><title>EU funds training network for young researchers</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/eu-foerdert-ausbildungsnetzwerk-fuer-junge-wissenschaftler0/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>Prof Anna K. H. Hirsch recently received a prestigious European grant with a total funding volume of 3.2 million euros to initiate an Innovative Training Network (ITN) in the framework of the Marie Skłodowska-Curie actions. Hirsch leads the department Drug Design and Optimization at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) in Saarbrücken, a site of the Helmholtz Centre…</content:encoded><description>Prof Anna K. H. Hirsch recently received a prestigious European grant with a total funding volume of 3.2 million euros to initiate an Innovative Training Network (ITN) in the framework of the Marie Skłodowska-Curie actions. Hirsch leads the department Drug Design and Optimization at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) in Saarbrücken, a site of the Helmholtz Centre…</description><pubDate>Thu, 25 Jun 2020 11:55:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/eu-foerdert-ausbildungsnetzwerk-fuer-junge-wissenschaftler0/</guid></item><item><title>Start of HZI’s nationwide antibody study</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/start-der-bundesweiten-seropraevalenzstudie-des-hzi0/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>Scientific data indicate that many COVID-19 cases are not recorded due to mild or asymptomatic infections. For this reason, there is at the time no sufficient data on how many people in Germany have already been infected and thus have established a presumed immunity against SARS-CoV-2. However, these data play an important role in assessing and forecasting the further course of the pandemic.</content:encoded><description>Scientific data indicate that many COVID-19 cases are not recorded due to mild or asymptomatic infections. For this reason, there is at the time no sufficient data on how many people in Germany have already been infected and thus have established a presumed immunity against SARS-CoV-2. However, these data play an important role in assessing and forecasting the further course of the pandemic.</description><pubDate>Wed, 17 Jun 2020 09:51:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/start-der-bundesweiten-seropraevalenzstudie-des-hzi0/</guid></item><item><title>Protection against the immune system</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/schutz-vor-dem-immunsystem/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>Virologists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig have identified a crucial survival factor in viruses. Their results were recently published in the scientific journal Proceedings of the National Academy of Sciences and could lead to a paradigm shift in virus immunology.</content:encoded><description>Virologists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig have identified a crucial survival factor in viruses. Their results were recently published in the scientific journal Proceedings of the National Academy of Sciences and could lead to a paradigm shift in virus immunology.</description><pubDate>Wed, 10 Jun 2020 09:00:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/schutz-vor-dem-immunsystem/</guid></item><item><title>CORESMA provides evidence-based data on measures against coronavirus</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/coresma-liefert-evidenzbasierte-daten-zu-massnahmen-gegen-das-coronavirus/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>The healthcare systems of many countries are not prepared for an outbreak of the coronavirus SARS-CoV-2. The Helmholtz Centre for Infection Research (HZI) in Braunschweig coordinates an international project to collect clinical, epidemiological and immunological data in order to provide a basis for further decisions in the corona crisis. In a highly competitive call for proposals, the CORESMA…</content:encoded><description>The healthcare systems of many countries are not prepared for an outbreak of the coronavirus SARS-CoV-2. The Helmholtz Centre for Infection Research (HZI) in Braunschweig coordinates an international project to collect clinical, epidemiological and immunological data in order to provide a basis for further decisions in the corona crisis. In a highly competitive call for proposals, the CORESMA…</description><pubDate>Tue, 09 Jun 2020 09:11:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/coresma-liefert-evidenzbasierte-daten-zu-massnahmen-gegen-das-coronavirus/</guid></item><item><title>Small Protein, Big Impact</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/kleines-protein-grosse-wirkung00/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria. Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding protein ProQ is involved in the activation of more than 250…</content:encoded><description>In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria. Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding protein ProQ is involved in the activation of more than 250…</description><pubDate>Thu, 04 Jun 2020 10:24:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/kleines-protein-grosse-wirkung00/</guid></item><item><title>With antibody tests and new active substances against SARS-CoV-2</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/mit-antikoerpertests-und-neuen-wirkstoffen-gegen-sars-cov-20-1/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>Federal Minister of Education and Research Karliczek and Lower Saxony’s Minister for Science and Culture Thümler were guests at the Helmholtz Centre for Infection Research (HZI) in Braunschweig today. The scientists at the HZI provided them with an overview of the current state of research on COVID-19, in particular a new nationwide epidemiological antibody study.</content:encoded><description>Federal Minister of Education and Research Karliczek and Lower Saxony’s Minister for Science and Culture Thümler were guests at the Helmholtz Centre for Infection Research (HZI) in Braunschweig today. The scientists at the HZI provided them with an overview of the current state of research on COVID-19, in particular a new nationwide epidemiological antibody study.</description><pubDate>Mon, 25 May 2020 16:58:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/mit-antikoerpertests-und-neuen-wirkstoffen-gegen-sars-cov-20-1/</guid></item><item><title>Interaction Between Immune System and Brain</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/interaktion-von-immunsystem-und-gehirn/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>Interferons are important messenger molecules in the immune system, assisting in the fight against pathogens such as influenza viruses and probably also SARS-CoV-2. However, interferon might also be involved in immune-brain interactions unrelated to an infection and may have an influence on learning ability. This is indicated by a study with mice from the Technische Universität Braunschweig,…</content:encoded><description>Interferons are important messenger molecules in the immune system, assisting in the fight against pathogens such as influenza viruses and probably also SARS-CoV-2. However, interferon might also be involved in immune-brain interactions unrelated to an infection and may have an influence on learning ability. This is indicated by a study with mice from the Technische Universität Braunschweig,…</description><pubDate>Wed, 20 May 2020 09:10:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/interaktion-von-immunsystem-und-gehirn/</guid></item><item><title>ifo Institute and Helmholtz Infection Researchers Favour Limited, Gradual Opening in Germany</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/ifo-und-helmholtz-infektionsforscher-fuer-begrenzte-schrittweise-oeffnungen/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>The ifo Institute and the Helmholtz Centre for Infection Research (HZI) have called for a “prudent, step-by-step opening process” in the coronavirus crisis. They recommend that the policy should be to do more testing to limit the increase in infections as the lockdown is progressively eased. “These measures are essential to limit the health and economic costs of the pandemic,” says a joint study…</content:encoded><description>The ifo Institute and the Helmholtz Centre for Infection Research (HZI) have called for a “prudent, step-by-step opening process” in the coronavirus crisis. They recommend that the policy should be to do more testing to limit the increase in infections as the lockdown is progressively eased. “These measures are essential to limit the health and economic costs of the pandemic,” says a joint study…</description><pubDate>Wed, 13 May 2020 10:51:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/ifo-und-helmholtz-infektionsforscher-fuer-begrenzte-schrittweise-oeffnungen/</guid></item><item><title>Prime Minister of Lower Saxony Stephan Weil and Minister Björn Thümler visit the Helmholtz Centre for Infection Research</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/niedersaechsischer-ministerpraesident-stephan-weil-und-minister-bjoern-thuemler-besuchen-das-helmhol/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>A distinguished visitor to the Helmholtz Centre for Infection Research: The Prime Minister of Lower Saxony Stephan Weil and Lower Saxony’s Minister of Science and Culture Björn Thümler visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig today. The focus of the visit was on current challenges and innovative solutions, especially in the fight against SARS-CoV-2 and the future…</content:encoded><description>A distinguished visitor to the Helmholtz Centre for Infection Research: The Prime Minister of Lower Saxony Stephan Weil and Lower Saxony’s Minister of Science and Culture Björn Thümler visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig today. The focus of the visit was on current challenges and innovative solutions, especially in the fight against SARS-CoV-2 and the future…</description><pubDate>Fri, 08 May 2020 16:58:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/niedersaechsischer-ministerpraesident-stephan-weil-und-minister-bjoern-thuemler-besuchen-das-helmhol/</guid></item><item><title>Adding flexibility to CRISPR targets in the genome</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/adding-flexibility-to-crispr-targets-in-the-genome/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>CRISPR technologies are revolutionary genome-editing tools that rely on molecular scissors called Cas nucleases to cut DNA. While these scissors can be programmed to cut virtually any sequence, that target must be flanked by a special sequence called a PAM (Protospacer Adjacent Motif). The PAM sequence is up to six nucleotides in length and can vary widely between Cas nucleases. To allow all…</content:encoded><description>CRISPR technologies are revolutionary genome-editing tools that rely on molecular scissors called Cas nucleases to cut DNA. While these scissors can be programmed to cut virtually any sequence, that target must be flanked by a special sequence called a PAM (Protospacer Adjacent Motif). The PAM sequence is up to six nucleotides in length and can vary widely between Cas nucleases. To allow all…</description><pubDate>Thu, 07 May 2020 10:47:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/adding-flexibility-to-crispr-targets-in-the-genome/</guid></item><item><title>Hope for antibody therapy against Covid-19</title><link>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/hoffnung-auf-antikoerpertherapie-gegen-covid-19/</link><source url="https://www.helmholtz-hzi.de:443/en/news-events/news/feed/pressreleases-feeds/rss2.xml" >News </source><content:encoded>Neutralizing antibodies are the interceptors of our immune system. They bind precisely to pathogens and prevent them from entering our cells. After an infection, the immune system needs about two weeks to produce mature antibodies. In severe cases of Covid-19, the body's immune reaction often comes too late for the patient. One option for acute treatment would therefore be to administer…</content:encoded><description>Neutralizing antibodies are the interceptors of our immune system. They bind precisely to pathogens and prevent them from entering our cells. After an infection, the immune system needs about two weeks to produce mature antibodies. In severe cases of Covid-19, the body's immune reaction often comes too late for the patient. One option for acute treatment would therefore be to administer…</description><pubDate>Thu, 07 May 2020 08:41:00</pubDate><guid>https://www.helmholtz-hzi.de:443/en/news-events/news/view/article/complete/hoffnung-auf-antikoerpertherapie-gegen-covid-19/</guid></item></channel></rss>